This announcement is a separate document:
永泰生物-B：自願性公告 藥品審評中心授予EAL治療肝癌 的突破性治療認定
IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT EAL WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR TREATMENT OF LIVER CANCER BY THE CENTER FOR DRUG EVALUATION
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.